Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced the appointment of Tamara Dillon to the position of Chief People Officer (CPO), effective May 31, and Larry Weiss to the position of Chief Legal Officer and Corporate Secretary, effective May 23.
“The addition of Tamara and Larry brings two extraordinary leaders with great depth of experience working within public companies, scaling talent, and respectively building and leading teams and functions to support growth,” said Dr. Todd Fruchterman, Butterfly Network’s President and Chief Executive Officer. “As we continue to execute on our strategy, expand the value we bring to global healthcare, and deliver upon our commitment to make Butterfly one of the most valuable and essential clinical assessment tools for medical professionals and the patients in their care, the roles of Chief People Officer and Chief Legal Officer are foundational to our organization. I look forward to working with and alongside Tamara and Larry in their new roles with Butterfly.”
Tamara joins Butterfly from Akebia Therapeutics where she served as Senior Vice President of Human Resources and Chief People Officer. During her almost eight years at Akebia she played an integral role in scaling the company and was instrumental in developing talent and culture. She also led the company’s Diversity Equity and Inclusion and Patient Advocacy functions. Before Akebia, Tamara served as Head of Human Resources, Global Discovery Chemistry at Novartis Institutes for BioMedical Research, where she was responsible for all aspects of human resources. She also held several key roles at Genzyme, a Sanofi Company.
Larry brings nearly 30 years of experience as an attorney, including 20 years in the medical device industry with Medtronic, Covidien, and Tyco Healthcare. Most recently, he served as Chief Legal Officer for Emulate, a venture capital backed life sciences start-up and as General Counsel and Corporate Secretary of Analog Devices, a publicly traded semiconductor company.
On her new role at Butterfly, Tamara commented, “I look forward to joining the Butterfly team and supporting its commitment to democratize healthcare through innovation and enabling more informed healthcare decisions. The people organization is the heartbeat to any healthy company, especially one with the important goal of benefiting patients around the world. I’m excited and proud to step into this role and be part of the Butterfly team.”
On his new role at Butterfly, Larry commented, “I am excited to be a part of the next chapter of growth and evolution at Butterfly. I’m extremely motivated by Butterfly’s mission to make medical imaging available to everyone in the world, enabling more informed care decisions at the bedside. Butterfly is pursuing a goal that is both important and transformative; I am honored to come aboard and be part of the talented Butterfly team.”
To learn more about Butterfly Network please go to: https://www.butterflynetwork.com/.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011 and listed on the New York Stock Exchange through a business combination with Longview Acquisition Corp., Butterfly created the world’s first handheld, single probe whole-body ultrasound system using semiconductor technology, the Butterfly iQ+. Butterfly’s mission is to democratize medical imaging and contribute to the aspiration of global health equity, making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Through its proprietary Ultrasound-on-Chip™ technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ can be purchased online today by healthcare practitioners in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Sweden, Switzerland, and the United Kingdom.
Butterfly iQ+ is a prescription device intended for trained healthcare professionals only.
The Editorial Team at Healthcare Business Today is made up of skilled healthcare writers and experts, led by our managing editor, Daniel Casciato, who has over 25 years of experience in healthcare writing. Since 1998, we have produced compelling and informative content for numerous publications, establishing ourselves as a trusted resource for health and wellness information. We offer readers access to fresh health, medicine, science, and technology developments and the latest in patient news, emphasizing how these developments affect our lives.
